Innovative and High Growth MedTech Companies to Present September 22-24, 2008
WASHINGTON, Sept. 2 /PRNewswire-USNewswire/ -- More than 50 U.S. and international medical technology companies have been selected to present at AdvaMed 2008: The MedTech Conference. Company presentations offer a unique business development and information sharing opportunity for innovators and market leaders in the cardiovascular, dental, diagnostics, imaging, metabolic disease/obesity, neurology, ophthalmology, orthopedics/spine, and wound care sectors.
"These dynamic companies were selected to present by a committee of leading business development and licensing executives, venture capitalists, bankers, and industry experts and will showcase a spectrum of cutting-edge medical innovations at varying stages in the product development lifecycle," said Kenneth Mendez, AdvaMed's Chief Administrative Officer. "In addition to the plenary sessions, MedTech partnering, and more than 50 educational panels, these company presentations offer investors and corporate business development officers the opportunity to identify projects and companies for potential investment, business collaboration and licensing activities."
Next Generation companies selected to present for 8 minutes include:
-- 20/20 GeneSystems (Rockville, Maryland)
-- Adnavance Technologies (San Diego, California)
-- Apeliotus Vision Science (Atlanta, Georgia)
-- Avita Medical (Cambridge, United Kingdom)
-- BioControl Medical (Yehud, Israel)
-- BioMarker Strategies (Baltimore, Maryland)
-- Chemica Technologies, Inc (Beaverton, Oregon)
-- Crospon (Galway, Ireland)
-- Endovalve, Inc. (Princeton, New Jersey)
-- eSight Corporation (Ottawa, Canada)
-- eToims Medical Technology LLC (Philadelphia, Pennsylvania)
-- Mesynthes (Wellington, New Zealand)
-- MicroTransponder, Inc. (Dallas, Texas)
-- NovaVision (Boca Rato
|SOURCE AdvaMed; AdvaMed 2008|
Copyright©2008 PR Newswire.
All rights reserved